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The c-Met receptor tyrosine kinase (MetR) is frequently
overexpressed and constitutively phosphorylated in a
number of human malignancies. Activation of the receptor
by its ligand, hepatocyte growth factor (HGF), leads to
increased cell proliferation, motility, survival and disrup-
tion of adherens junctions. In this study, we show that
hTid-1, a DNAJ/Hsp40 chaperone, represents a novel
modulator of the MetR signaling pathway. hTid-1 is a
co-chaperone of the Hsp70 family of proteins, and has
been shown to regulate a number of cellular signaling
proteins including several involved in tumorigenic and
apoptotic pathways. In this study we demonstrate that
hTid-1 binds to unphosphorylated MetR and becomes
dissociated from the receptor upon HGF stimulation.
Overexpression of the short form of hTid-1 (hTid-1S)i n
786-0 renal clear cell carcinomas (RCCs) enhances MetR
kinase activity leading to an increase in HGF-mediated
cell migration with no discernible effect on cell prolifera-
tion. By contrast, knockdown of hTid-1 markedly impairs
both the onset and amplitude of MetR phosphorylation in
response to HGF without altering receptor protein levels.
hTid-1-depleted cells display defective migratory proper-
ties, coincident with inhibition of ERK/MAP kinase and
STAT3 pathways. Taken together, our ﬁndings denote
hTid-1S as an essential regulatory component of MetR
signaling. We propose that the binding of hTid-1S to
MetR may stabilize the receptor in a ligand-competent
state and this stabilizing function may inﬂuence
conformational changes that take place during the
catalytic cycle that promote kinase activation. Given
the prevalence of HGF/MetR pathway activation in
human cancers, targeted inhibition of hTid-1 may be a
useful therapeutic in the management of MetR-dependent
malignancies.
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Introduction
hTid-1, a DnaJ chaperone protein of the Hsp40 family,
is the human homologue of the drosophila tumor
suppressor Tid56, the product of the lethal tumorous
imaginal disc gene (l(2)tid). In drosophila, homozygous
recessive mutations of l(2)tid cause defects in differ-
entiation and morphogenesis of larval imaginal
discs leading to neoplastic growth of these cells into
lethal tumors (Kurzik-Dumke et al., 1992, 1995). The
human TID1 gene gives rise to two major alternative
splice isoforms: a 43-kDa long form hTid-1L and a
shorter 40kDa hTid-1S variant, both of which
are widely expressed (Trentin et al., 2001; Yin and
Rozakis-Adcock, 2001). All hTid-1 isoforms consist
of a N-terminal DNA ‘J-domain’, which is a highly
conserved region present in all DNA J/Hsp40 family
members that mediates binding to Hsp70 heat shock
proteins (Hsps) (Wall et al., 1994) (Figure 2a). Follow-
ing the DNA J-domain, is a glycine/phenylalanine
rich (G/F) hinge region and a less conserved cysteine
(Cys)-rich domain of B75 aa in length, which is thought
to facilitate the stabilization of target proteins with
Hsp70/90 heterocomplexes (Banecki et al., 1996). The
COOH-terminal region of all DNA J proteins is the least
conserved and is responsible for conferring substrate-
binding speciﬁcity.
hTid-1 has been implicated in the control of a number
of signaling pathways including those involved with cell
growth, survival, migration and tumor development.
Several examples include the binding of hTid-1 to Ras
p120 GTPase activating protein (GAP), a negative
regulator of Ras (Trentin et al., 2001), binding and
inhibition of NF-kB leading to growth arrest and cell
death (Cheng et al., 2002, 2005), and suppression
of Jak/STAT signaling though an interaction with
Jak2 and interferon-g receptor (Sarkar et al., 2001).
In addition, hTid-1 has been shown to associate with
tumor suppressor proteins such as Patched and adeno-
matous polyposis coli (APC) proteins linked to the
development of basal cell carcinoma and colorectal
cancer, respectively (Kurzik-Dumke and Czaja, 2007;
Wakabayashi et al., 2007). More recently, we identiﬁed
the von Hippel-Lindau tumor suppressor (pVHL) as a
novel binding partner of hTid-1 (Bae et al., 2005).
Mutations in pVHL are found in a majority of sporadic
renal cell carcinomas, hemangioblastomas and pheo-
chromocytomas. The majority of these mutations hinder
the ability of pVHL, a component of the E3 ubiquitin
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a (HIFa) for polyubiquitinated degradation (Ohh et al.,
1999). HIF1a is a transcription factor that activates a
number of genes involved in adaptation to hypoxia,
including vascular endothelial growth factor (VEGF)
and transforming growth factor a (TGFa) (Iliopoulos
et al., 1996). We have reported that recombinant
hTid-1 through direct association with pVHL, enhances
pVHL/HIF1a complex formation and promotes HIF1a
degradation (Bae et al., 2005). Accordingly, hTid-1 is
able to inhibit VEGF expression and angiogenesis both
in vitro and in vivo.
hTid-1 is also known to interact with and inﬂuence
the activity of receptor tyrosine kinases (RTKs),
including ErbB-2, Trk and muscle-speciﬁc kinase MuSK
(Kim et al., 2004; Liu et al., 2005; Linnoila et al., 2008).
The interaction between ErbB-2 and Tid-1 was ﬁrst
described by Kim et al., who reported that exogenenous
hTid-1 expression promotes the ubiquitination and
degradation of ErbB-2 in human breast cancer cell lines
and suppresses the in vitro and in vivo growth of
ErbB2-dependent mammary carcinomas (Kim et al.,
2004). The Trk family (TrkA, -B and -C) of RTKs have
also been identiﬁed as hTid-1 binding proteins. Trk
RTKs are activated by neurotrophins such as nerve
growth factor and brain-derived neurotrophic factor.
In this instance, hTid-1 inducibly associates with
activated Trk receptors and promotes nerve growth
factor-dependent neurite differentiation in nnr5-TrkA
cells, coincident with sustained ERK/MAP kinase
activity (Liu et al., 2005). More recently, hTid-1 was
shown to complex with MuSK, a major component of
the agrin receptor, and established as an essential
intermediate in postsynaptic formation and transmis-
sion at neuromuscular junctions (Linnoila et al., 2008).
In this study we show that hTid-1 serves as an
essential regulator of the c-Met receptor tyrosine kinase
(MetR), a member of the RTK family that is activated
by the hepatocyte growth factor/scatter factor (HGF/
SF). Although a previous study by Schaaf et al. reported
the binding of the oncogenic fusion protein, tpr-met, to
the precursor form of hTid-1, the functional signiﬁcance
of this interaction was not addressed (Schaaf et al.,
2005). MetR is overexpressed and hyperactivated
in a number of human cancers including gliomas,
osteosarcomas, breast and prostate carcinomas (Rong
et al., 1994; Benvenuti and Comoglio, 2007) and often
associated with tumor metastasis and poor clinical
prognosis (Ferracini et al., 1995; Hov et al., 2004).
It is noteworthy that both MetR and its ligand HGF
have been shown to be overexpressed in renal clear cell
carcinomas (RCCs), tumors often associated with
hereditary or spontaneous loss of pVHL (Natali et al.,
1996; Pennacchietti et al., 2003). Moreover, biochemical
studies have linked inactivation of VHL in RCCs with
constitutive tyrosine phosphorylation of MetR leading
to disruption of adherens junctions and the acquisition
of an invasive cell phenotype (Nakaigawa et al., 2006).
Accordingly, MetR activity in RCCs can be inhibited by
exogenous expression of wild-type VHL (Koochekpour
et al., 1999). In light of the many levels at which
the hTid-1 and VHL pathways coincide, we sought to
investigate the contribution of hTid-1 in the regulation
of the Met receptor-signaling pathway.
Results
hTid-1S and hTid-1L modulate MetR phosphorylation
levels independent of pVHL
We ﬁrst set out to determine if hTid-1 inﬂuences pVHL-
mediated inhibition of MetR phosphorylation by over-
expressing hTid-1 in both 786-0 RCC parental cells
(786-0-VHL) and their stable transformants expressing
exogenous wild-type VHL (786-0 þVHL) (Figure 1a).
Adenoviruses expressing hTid-1S (Ad-hTid-1S), hTid-1L
(Ad-hTid-1L) or GFP alone (Ad-GFP) were generated
and used to transduce RCC cells. Virally infected cells
were serum-starved overnight and either left untreated
or stimulated with 40ng/ml HGF for 10min. The use
of this concentration of HGF results in robust auto-
phosphorylation of MetR in 786-0 parental cells, as
determined by immunoblotting for the activation loop
phosphotyrosines 1234 and 1235 (pMet) (Figure 1a).
Consistent with the data from Nakaigawa et al.
(Nakaigawa et al., 2006), HGF-stimulated MetR phos-
phorylation was markedly inhibited in VHL-reconsti-
tuted 786-0 cells compared with parental 786-0 cells
(Figure 1a, lane 2 vs lane 8). We found that over-
expression of either Ad-hTid-1S or Ad-hTid-1L
had no discernible effect on pMet levels in the VHL-
proﬁcient 786-0 cells. By contrast, overexpression of
hTid-1S in 786-0 parental cells resulted in increased
pMet levels in response to HGF treatment compared
with GFP controls, whereas hTid-1L had a slight
inhibitory effect. It should be pointed out that this
change in phosphorylation status was not associated
with changes in MetR protein levels.
To assess whether these ﬁndings represented a cell-
speciﬁc idiosyncrasy, similar experiments were per-
formed in the VHL-null invasive breast carcinoma cell
line MDA-MB-231(Zia et al., 2007). We were able to
conﬁrm that hTid-1S expression enhanced, whereas
hTid-1L inhibited MetR phosphorylation in response
to HGF (Figure 1b). By contrast, overexpression of
either hTid-1S or hTid-1L in A549 cells, a VHL-
proﬁcient lung carcinoma cell line, had no impact on
MetR activity (Figure 1c). Taken together, these
ﬁndings suggest that both isoforms of hTid-1 have a
modulatory effect on MetR activation in VHL null cells.
In light of this observation, all further experiments were
performed using 786-0 parental cells.
hTid-1 proteins bind to unphosphorylated MetR
To determine whether hTid-1 affects MetR activation
through an interaction with the receptor, complex
formation was ﬁrst assessed using GST-Tid-1 fusion
proteins. (Figure 2). Conﬂuent layers of 786-0 RCC cells
were serum-starved overnight and the following day the
cells were either left untreated or stimulated with HGF
for 10minutes. Lysates from both untreated and HGF
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Oncogenetreated 786-0 RCC cells were incubated with either GST
alone or the GST-full length hTid-1S construct. The
resulting complexes were subjected to western blot
analysis using either anti-Met receptor or anti-phospho-
tyrosine 4G10 speciﬁc antibodies. To ensure cell lysates
were incubated with equivalent amounts of GST
proteins, the lower portion of the sodium dodecyl
sulfate–PAGE gel was stained with Coomassie blue.
(Figure 2b). An interaction between the recombinant
GST-hTid-1S and MetR was observed in both serum-
starved and HGF-treated lysates. Probing with 4G10
antiphosphotyrosine antibodies revealed that HGF
mounts robust activation of the MetR (Figure 2b upper
panel, lane 1 and 2), yet no discernible interaction
between GST-hTid-1 and phosphorylated MetR was
observed, indicating that hTid-1 preferentially binds to
Met receptors in the kinase-inactive state.
The next step was to delineate which domain(s) of
hTid-1 confer binding to MetR. To this end, three
deletion constructs, each expressing a key hTid-1
domain, were expressed as GST fusion proteins in
bacteria: (1) hTid1-J domain, the region responsible for
mediating DNAJ/Hsp70 protein interactions, (2) G/F/
CYS-rich domain, a zinc-ﬁnger-like domain in the
central region of hTid-1 and (3) hTid1-C-terminus,
the region implicated in confering substrate binding
Figure 1 hTid-1 modulates MetR tyrosine phosphorylation. (a) 786-0 parental RCC cells (786-0–VHL) and 786-0 cells in which VHL
has been reintroduced (786-0þVHL) were infected with adenoviruses expressing either GFP alone (Ad-GFP), hTid-1S (Ad-hTid-1S)o r
hTid-1L (Ad-hTid-1L) as indicated. Cells were serum-starved overnight and either left untreated ( ) or treated with 40ng/ml HGF (þ).
Whole-cell lysates were immunoblotted with antibodies speciﬁc to phospho-Met (Tyr1234/1235 in the activation loop; pMet), total
Met, hTid-1, VHL and b-actin. Met antibodies detect Met molecules of 170kDa (precursor) and 140kDa (mature b-chain).
(b) MDA-MB-231 cells were infected and treated as in panel a, except that cells were treated with HGF over the indicated time course.
(c) Experiment was repeated as in panel b using A549 lung cancer cells.
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Oncogene(Figure 2a). 786-0 cell lysates that had either been left
untreated or stimulated with HGF were incubated
with the indicated GST–hTid-1 fusion proteins and
complexes were subsequently subjected to western blot
analysis. Interestingly, immunoblotting with anti-MetR
antibodies revealed that the interaction between hTid-1
and MetR is mediated through the J-domain of Tid1
and not the C-terminal substrate-binding domain
(Figure 2b). The light MetR immunoreactive band
present in the GST- Tid1-G/F/Cys-pull-downs likely
reﬂect a nonspeciﬁc interaction with the GST moiety, as
similar nonspeciﬁc signals appear in GST controls.
To test whether MetR and hTid-1 associate in vivo,
co-immunoprecipitation experiments were performed
in 786-0 cells (Figure 2c). Cell lysates from both
serum-starved and HGF-stimulated cells were immuno-
precipitated with anti-MetR antibodies and the resulting
immunocomplexes were probed with anti-hTid-1
antibodies. Our results revealed that although both
isoforms of hTid-1 were present in MetR immune
complexes, the short isoform of hTid-1 was preferen-
tially associated with MetR in vivo. Similar observations
were made with exogenously expressed Ad-hTid-1S and
Ad-hTid-1L (Figure 2e). We also noted that the MetR/
hTid-1 complex preformed under basal conditions was
dissociated in response to HGF (Figure 2c, lane 3 vs
lane 4). Interestingly, overexpression of recombinant
Ad-hTid-1S but not Ad-hTid-1L displayed prolonged
association with MetR, which may serve to promote
signal ampliﬁcation (Figure 2e). Our data suggest that
both hTid-1 isoforms preferentially interact with the
kinase inactive conformer of MetR and that ligand
binding stimulates receptor conformational changes,
which release MetR from the hTid-1 chaperone machin-
ery. In support of this observation, immunoprecipita-
tion assays using phosphospeciﬁc MetR antibodies that
recognize the twin phosphotyrosines Tyr-1234/1235
in the activation loop of MetR clearly established that
the activated receptor does not bind hTid-1 (Figure 2d).
It should be pointed out that immunoprecipitation
assays with hTid-1 antibodies failed to demonstrate
detectable binding between hTid-1 and MetR
(Figure 2c, right panel). One possible explanation is
that our polyclonal antibodies raised against hTid-1
disrupt hTid-1/MetR complexes, which is an observa-
tion we have previously reported for other Tid-1/
substrate interactions (Trentin et al., 2001).
The ability of MetR to serve as a direct binding
partner of hTid-1 prompted us to examine the sub-
cellular location at which this interaction occurs.
Previous data from our laboratory and others have
shown that hTid-1 is distributed not only within the
mitochondrial compartment but found at the plasma
membrane, cytosol and nucleus depending on the
particular cell type (Sarkar et al., 2001; Trentin et al.,
2001; Linnoila et al., 2008). Analysis of immunoﬂuor-
escent staining patterns under serum-starved conditions
revealed that hTid-1 and MetR exhibited a punctate
distribution throughout the cytosolic compartment
with areas of colocalization (Figure 3, top panels) that
may represent the chaperoning of MetR molecules by
Figure 2 The J domain of hTid-1 selectively interacts with kinase-
inactive MetR. (a) A schema depicting the GST constructs used
in the GST pull-down experiments: full-length Tid-1 construct, a
J-domain construct, a G/F/Cys-rich and C-terminal construct.
(b) 786-0 RCC cells were serum-starved and either left untreated
( ) or treated with 40ng/ml HGF (þ). Lysates were incubated
with the indicated GST proteins and the resulting complexes were
subjected to immunoblotting with speciﬁc antibodies to MetR, and
a phosphotyrosine speciﬁc antibody (pTyr 4G10). To ensure equal
amounts of GST proteins used, the SDS–PAGE gel was stained
with Coomassie blue (bottom panel). (c) 786-0 RCC cells were
serum-starved and either left untreated ( ) or treated with HGF
(þ). Cell lysates were immunoprecipitated with Met or hTid-1
antibodies and immune complexes were resolved by SDS-PAGE
and analyzed by western blotting using antibodies speciﬁc to
phospho-Met (Tyr1234/1235 in activation loop, pMet), total Met
and hTid-1. (d) Cell lysates processed as shown in panel c were
immunoprecipated with pMet antibodies and immune complexes
probed with Tid-1 and pMet antibodies. (e) 786-0 Tid1 null cells
were infected with adenoviruses expressing either Ad-GFP,
Ad-hTid-1S or Ad-hTid-1L and stimulated with HGF as indicated.
Cell lysates were immunoprecipitated with Met antibodies and
immunoblotted with either total Met, Tid-1 or pMet antibodies.
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HGF, we observed that MetR accumulated in a
perinuclear region of the cell (Figure 3, lower panels)
and this shift in topology is consistent with previous
studies demonstrating that MetR transits to perinuclear
foci suggestive of association with late endosomes/
lysosomes (Hammond et al., 2001; Sangwan et al.,
2008).
hTid-1S enhances HGF-mediated cell migration
HGF is a potent motogen, mediating epithelial cell
scattering, branching tubule formation and invasion of
cells through a matrix (Birchmeier et al., 2003). Seeing
as hTid-1S overexpression results in enhanced activation
of MetR by HGF (Figure 1), we wanted to determine
whether this would inﬂuence HGF-mediated migration.
The ﬁrst experimental approach used to examine
migration was a transwell assay. 786-0 RCC cells were
infected with Ad-hTid-1S, Ad-hTid-1L or Ad-GFP
viruses as control and following serum-starvation,
75000 cells were resuspended in DMEM with 0.5%
bovine serum albumin (BSA) and plated in the upper
chamber of a transwell ﬁlter. Using HGF as a
chemoattractant in the lower chamber, the number of
cells that migrated through the 8-mm porous membrane
was counted. After 24h of incubation, the number of
hTid-1S overexpressing cells that had migrated through
the ﬁlter was signiﬁcantly higher (Po0.05) than the
number of GFP-infected control cells (Figure 4). There
was no signiﬁcant difference between hTid-1L over-
expressing cells and control cells. This demonstrates that
hTid-1S is able to promote HGF-mediated migration
and is consistent with the enhanced MetR activation
that is observed with hTid-1S overexpression.
A wound closure assay was used as an alternative
measure of cellular migration. 786-0 RCC cells were
infected with Ad-GFP, Ad-hTid-1S or Ad-hTid-1L
viruses, grown to conﬂuency and serum-starved
overnight. The following day a uniform wound was
made in the conﬂuent layer of cells and the width of
the wound following its formation was measured at the
indicated time points. The cells were either left untreated
or stimulated with HGF over the time course indicated.
The wound in 786-0 cells infected with Ad-hTid-1S
closed signiﬁcantly faster than that of the control cells
(Figure 5, Po0.05), which is consistent with the
increased migration observed in the transwell assay.
This effect was observed in the presence of serum-free
media, as well as in HGF-treated 786-0 cells (Figures 5a
and b) suggesting that hTid-1S may also be inﬂuencing
additional motogenic signaling pathways other than
HGF/MetR. Consistent with the results from the
transwell migration assay there was no signiﬁcant
effect of hTid-1L on wound closure compared with
control cells.
To determine whether hTid-1 has any effect on the
growth rate of 786-0 cells, cell proliferation assays were
performed both in untreated (Figure 6a) and HGF-
stimulated (Figure 6b) cells. 786-0 cells were infected
with adenoviruses expressing hTid-1S, hTid-1L or a GFP
control, serum-starved overnight and the following
day (day 0) were counted and plated in 24-well plates.
On each indicated day (up to 7 days post-infection)
Figure 3 Localization of MetR with hTid-1. 786-0 cells were seeded on coverslips and either left untreated (-HGF) or stimulated with
HGF (þHGF) at 371C for 10min. Coverslips were ﬁxed in 2% PFA and stained with MetR and Tid-1 antibodies and images
captured with a Zeiss LSM 410 Laser Scanning Confocal Microscope. Yellow staining represents colocalization between endogenous
hTid-1 (red) and MetR (green).
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Oncogenetriplicate wells for each adenoviral condition were
trypsinized and the number of cells counted. Our data
indicate that there was no signiﬁcant difference in the
proliferation rates of either hTid-1S or hTid-1L-infected
cells compared with GFP controls, suggesting that
hTid-1 has no effect on cellular proliferation in the
786-0 RCC tumor cell model.
hTid-1 modulates HGF-mediated MAPK phosphorylation
Activation of both PI3K-mediated and MAPK-
mediated signaling pathways have been implicated in
HGF-induced migration. To determine which of these
pathways, if any, were responsible for mediating the
increased migration in hTid-1S overexpressing cells, we
examined the phosphorylation status of both Akt and
Erk1/2. hTid-1S overexpression resulted in a robust
HGF-dependent activation of Erk1/2 compared with
control cells, whereas Akt phosphorylation at Ser473
was unchanged (Figure 7). These results demonstrate
that hTid-1S enhances HGF-dependent MAPK activa-
tion, but not PI3K signaling, to promote cellular
migration in 786-0 RCC cells.
hTid-1 knockdown inhibits MetR activation and
migration
To add validity to the results obtained so far using hTid-
1 overexpression, we next sought to investigate whether
hTid-1 proteins have a physiological role in c-Met-
dependent signaling by using RCC cells where hTid-1
expression was silenced. To this end, 786-0 cells stably
expressing either a control nonspeciﬁc short interfering
(si) RNA or a gene speciﬁc siTid-1 construct were
serum-starved overnight and exposed to HGF ligand for
varying time points. Whole-cell lysates were collected
and western blotting was used to analyze phospho-Met
(Tyr1234/Tyr1235, pMet), total MetR and hTid-1 levels
(Figures 8a and b). We found that in the absence of
endogenous hTid-1 proteins there was a marked
inhibition of MetR phosphorylation in HGF-treated
cells, consistent with the idea that hTid-1 chaperone
function was necessary for efﬁcient ligand-dependent
activation of MetR. We subsequently assessed whether
hTid-1 silencing inﬂuences the migratory properties of
786-0 cells in response to HGF. Transwell migration
assays performed using HGF as a chemoattractant
revealed that stable depletion of endogenous hTid-1
proteins severly compromises 786-0 migration (B70%
inhibition) when compared with siRNA control cells
(Figure 8b). Moreover, we observed that this suppres-
sion in cell motility correlated with an inhibition in
Erk1/2 and STAT3 activation in response to HGF
treatment (Figure 7c).
Discussion
Molecular chaperones, best known for their role in the
biogenesis and folding of nascent polypeptides, have
Figure 4 hTid-1S enhances HGF-mediated migration. (a) hTid-1S (Ad-hTid-1S) and hTid-1L (Ad-hTid-1L) were overexpressed in
786-0 RCC cells via adenoviral infection. An adenovirus expressing GFP alone was used as a control (Ad-GFP). The cells were serum-
starved overnight and plated in the upper chamber of a transwell chamber, using HGF as a chemoattractant in the lower chamber.
After 24h of incubation, the cells that had migrated were ﬁxed and stained with Diff-Quik. Representative pictures from each ﬁlter are
shown. (b) Lysates from cells infected simultaneously as those used for migration were immunoblotted with anti-hTid-1 to conﬁrm
efﬁcient hTid-1 overexpression. (c) Migrated cells were counted in ﬁve individual ﬁelds and averaged. The results are pooled from three
independent experiments. An unpaired t-test was used to determine signiﬁcance between GFP and hTid-1S or hTid-1L overexpressing
cells. *, a P-value of o0.05 was considered signiﬁcant.
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Oncogenean integral role in numerous intracellular signaling
pathways, including those involved with cell survival
and growth regulation. Many of these chaperones were
originally identiﬁed as Hsps and belong to one of four
major families: Hsp 60, Hsp 70, Hsp 90 and Hsp100,
which rely on accessory proteins or cochaperones
(for example, DNA J/Hp40, Cdc37, Immunophilin) to
determine their functional speciﬁcity (Frydman et al.,
1994; Duina et al., 1996; Freeman et al., 1996; Hartl,
1996; Chang et al., 1997). Hsps have a critical role in
protecting cells from environmental and physiologic
stresses or pathological conditions that lead to the
appearance of misfolded, mutated or otherwise da-
maged molecules (Jolly and Morimoto, 2000). As such,
Hsp function in cancer cells is often co-opted to support
malignant transformation, by serving as a biochemical
buffer that permits aberrant functioning of mutated
oncoproteins and escape from genotoxic cell death.
Hsp70 and Hsp90 are known to govern the biological
activity of a number of cancer-associated signaling
proteins. Most of the known clients of Hsp90 can be
divided into two categories, signaling kinases (for
example, ErbB-2, IGF-1R, v-Src, PKR, Akt, Raf-1)
and transcription factors (steroid hormone receptors,
p53, HIF1a) (Pratt and Toft, 2003). Recruitment of
Hsp90 to these substrates stabilizes their conformations,
facilitating ligand binding, substrate phosphorylation
or subsequent protein interactions. Contrary to the
pro-tumorigenic and antiapoptotic properties of Hsp70
and Hsp90 proteins, hTid-1 encodes the ﬁrst member of
the DNAJ/Hsp40 chaperone family to be classiﬁed
as a tumor suppressor (Trentin et al., 2001; Yin and
Rozakis-Adcock, 2001; Chen et al., 2009; Ahn et al.,
2010). Biochemical evidence suggests that hTid-1 may
exert its antitumor function by interacting with and
inhibiting the activity of mitogenic or oncogenic
proteins such as human papillomavirus E7 oncoprotein
(Schilling et al., 1998), Jak2 kinase (Sarkar et al., 2001)
and ErbB-2 (Kim et al., 2004). Subsequent studies
demonstrated that hTid-1 represses NFkB activity
induced by HTLV-1 Tax and cytotoxic stimuli including
TNFa, cisplatin and MMC, by directly binding and
Figure 5 hTid-1S enhances HGF-mediated wound closure. (a) 786-0 RCC cells were infected with adenoviruses expressing either
hTid-1S (Ad-hTid-1S) or hTid-1L (Ad-hTid-1L). A GFP expressing adenovirus (Ad-GFP) was used as a control. At 24-h post-infection,
the cells were serum-starved for an additional 24h. A uniform wound was made in the conﬂuent cell layer at 0h. The cells were then
incubated with fresh serum-free media. (b) The same experiment was performed as shown in panel a, except that 5ng/ml HGF
was added to the serum-free media at 0h. Pictures of the wound at speciﬁc locations were taken at the indicated time points. (c, d) The
wound width was calculated using Simple PCI software, and the relative wound closure was calculated setting wound closure of
the control condition at 24h as 1. The data presented is a representative experiment from three independent experiments. An unpaired
t-test was used to calculate signiﬁcance of either hTid-1S or hTid-1L overexpressing cells compared with the control at each time point.
*, a P-value of o0.05 was considered signiﬁcant.
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Oncogeneinhibiting IKK kinase activity and in so doing modulat-
ing apoptotic signal transduction in mammalian
cells. hTid-1 also has a direct bearing on the function
of a number of tumor suppressor proteins such as VHL,
p53 and adenomatous polyposis coli, however, in this
instance it serves to promote their role in cell-death
pathways by inﬂuencing several facets of their
signaling capacity such as their subcellular localization,
assembly into multiprotein complexes and/or coupling
to the proteosomal machinery (Bae et al., 2005;
Kurzik-Dumke and Czaja, 2007; Ahn et al., 2010; Qian
et al., 2010).
The data presented herein introduces a novel role for
hTid-1 in the regulation of c-Met receptor signaling in
renal cell carcinomas which are often associated with
hereditary or spontaneous loss of VHL. Biochemical
studies indicate that VHL-negative RCCs display a
heightened response to HGF-driven activities and
correlate with increased cell motility, matrix invasion
and tubulogenesis (Koochekpour et al., 1999; Peruzzi
and Bottaro, 2006; Peruzzi et al., 2006; Zia et al., 2007).
The source of this enhanced MetR signaling in VHL-
defective RCCs is somewhat controversial with some
groups pointing to changes in the activity of dowstream
effectors such as HIF2a, b-catenin, E-cadherin and
TIMPs, which synergize with HGF, while others
observe changes in the activity of the c-Met receptor
itself (Birchmeier et al., 2003). In this study, we provide
evidence that hTid-1 inﬂuences the dynamics of c-Met
receptor activation in VHL-null RCCs. hTid-1 seems to
achieve this effect through a direct interaction with
MetR in its catalytically inactive unbound state.
Although MetR is found to co-immunoprecipitate with
both long and short isoforms of hTid-1 under basal
conditions, there is preferential binding to Tid-1S.
Similar observations were noted for the MuSK receptor
that selectively interacts with hTid-1S (Linnoila et al.,
2008). Signiﬁcantly, we and others have reported
differential activities of these two Tid1 isoforms in
cancer cell lines (Syken et al., 1999, 2003; Edwards and
Munger, 2004; Trentin et al., 2004). In the context of
RCC cells, overexpression of hTid-1S in parental 786-0
cells is seen to enhance HGF-mediated MetR autopho-
sphorylation on tyrosine residues Y1234 and Y1235
within the activation loop of the TK domain without
altering steady levels of the protein, whereas hTid-1L
shows a modest inhibition of MetR activity. Moreover,
siRNA-mediated depletion of endogenous hTid-1
Figure 6 hTid-1 overexpression does not affect 786-0 cellular
proliferation. (a) 786-0 cells were infected with adenoviruses
expressing either GFP, hTid-1S or hTid-1L, and serum-starved
overnight. A total of 10000 cells/well were plated in 24-well plates
on day 0. Triplicate wells were counted with a haemocytometer on
the indicated days post-infection. The mean and s.d. of each
triplicate time point was determined. (b) Experiment was repeated
as shown in panel a except 2500 cells/well were plated in each
well of a 24-well plate and cells were treated with 100ng/ml HGF.
(c) Lysates from adenoviral infected 786-0 cells from panels a
and b were subjected to immunoblot analysis using anti-hTid-1
antibodies.
Figure 7 Enhanced motility is associated with increased Erk1/2
activation. 786-0 RCC cells were infected with adenoviruses
expressing hTid-1S (Ad-hTid-1S) or GFP as a control (Ad-GFP).
The cells were serum-starved overnight and treated with HGF
for the indicated time periods. Whole-cell lysates were resolved by
SDS–PAGE and analyzed by western blotting with antibodies
speciﬁc to phospho-Met (Tyr1234/1235; pMet), total Met, phos-
pho-Erk1/2, total Erk1/2, pAkt, total Akt and hTid-1.
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amplitude of HGF-stimulated phosphorylation of the
receptor, establishing that the protein chaperoning
function of hTid-1S is essential for ligand-induced
conformational transitions in the kinase domain that
lead to receptor activation. However, it should be
pointed out that the regulatory impact of hTid-1 on
MetR was not observed in VHL proﬁcient 786-0 or
A549 lung carcinoma cell lines. Thus, it is possible that
hTid-1 functions through an alternative mechanism to
that proposed for the regulation of MetR activation by
VHL, which interestingly is observed only under high
cell density conditions. Another possibility is that in
VHL-proﬁcient cells, MetR requires only limited assis-
tance from Tid-1S to maintain the kinase domain in a
readily activatable state; whereas under VHL-null
conditions the receptor may adopt a more unstable or
labile conformation that leads to a higher requirement
for Tid-1 function in the stabilization and/or allosteric
activation of MetR.
Our GST-pull-down assays revealed that binding of
hTid-1 to MetR is mediated through its J-domain,
which was somewhat suprising given that hTid-1 has
been reported to interact with other RTK client proteins
such as ErbB2, Trk and MuSK via its C-terminal
substrate-binding region (Kim et al., 2004; Liu et al.,
2005; Linnoila et al., 2008). In these instances, the
authors propose that the effect of hTid-1 on RTK
function is dependent on its ability to couple to Hsp70
chaperones via its DNAJ domain. Coincidently, MetR
is not unique on its reliance on the hTid-1 DNAJ
region for complex formation, as IkB and IKK
interaction domains on hTid-1 have also been mapped
to the J domain (Cheng et al., 2005). Currently there
is no published evidence suggesting that MetR is a
Hsp70 substrate, and our own attempts at detecting
an interaction between the two proteins have been
unsuccessful (data not shown). However, there are a
number of independent studies that provide support for
MetR as a Hsp90 client protein. Inhibition of Hsp90
function via geldanamycin treatment has been shown to
downregulate MetR protein expression levels suggesting
that Hsp90 is necessary for stabilization of MetR in its
mature conformation (Webb et al., 2000; Maulik et al.,
2002; Lesko et al., 2007). Disruption of Hsp90 function
has also been associated with inhibition of MetR
activation by HGF (Koga et al., 2007). It is therefore
possible that hTid-1 modulates MetR phosphorylation
as a part of a larger Hsp90 multicomponent chaperone
complex. At present, however, we cannot rule out the
possibility that hTid-1 can chaperone client proteins
such as MetR in its own right, as well as indirectly
through modulation of HSP70/Hsp90 function.
In this study, we also addressed the role of hTid-1 on
downstream MetR signaling in RCC cells. The increased
MetR phosphorylation observed upon hTid-1S over-
expression translated into enhanced HGF-mediated cell
migration. This correlated with increased activation of
the MAPK signaling cascade as measured by Erk1/2
phosphorylation. The activities of both PI3K and
Figure 8 hTid-1 knockdown inhibits Met activation and HGF-mediated migration. (a) Left panel, 786-0 RCC cells that had been
stably infected with either a control lentivirus or a si-hTid-1 expressing lentivirus were serum-starved overnight and treated with HGF
for the indicated time points. Whole-cell lysates were collected and resolved by SDS–PAGE. Western blotting was used to analyze
phospho-Met (Tyr1234/Tyr1235, pMet), total Met and hTid-1 levels. Right panel, densitometric analysis was used to determine the
degree of Met phosphorylation relative to total Met levels and is shown as the relative pixel density of pMet:Met compared with
untreated cells. (b) Left panel, 786-0 cells that have been stably infected with either a control lentivirus or a si-hTid-1 expressing
lentivirus were serum-starved overnight and used in a transwell migration assay. A total of 7.5 10
5 cells were plated in the upper
chamber with HGF in the lower chamber. Cells were allowed to migrate for 24h, and representative pictures for each ﬁlter is shown.
Right panel, The number of cells that migrated was counted in ﬁve individual ﬁelds/ﬁlter and the average number of cells/ﬁeld was
calculated, and is shown as a ratio to the number of cells that migrated in the control condition. The data shown represent pooled data
from three independent experiments. An unpaired t-test was used to determine signiﬁcance. *, a P-value of o0.05 was considered
signiﬁcant. (c) hTid-1 knockdown inhibits signaling through Erk1/2 and STAT3. 786-0 RCC cells that had been stably infected with
either a control lentivirus or a si-hTid-1 expressing lentivirus were serum-starved overnight and treated with 10ng/ml HGF for the
indicated time points. Whole-cell lysates were prepared and subjected to immunoblot analysis using antibodies speciﬁc for phospho-
Met (Tyr1234/1235, pMet), total Met, pSTAT3, total STAT3, phospho-Erk1/2 (pErk1/2), hTid-1 and b-actin.
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HGF-driven cell motility. However, in this context, we
saw no apparent difference in PI3K-dependent AKT
phosphorylation at Ser473 when hTid-1S was over-
expressed, despite the fact that an overall enhancement
in MetR activation was observed. Our results are in
alignment with independent reports demonstating that
hTid-1S overexpression selectively modulates the
MAPK branch of ErbB2 and Trk receptor signaling
pathways with no discernible effect on the activity of
AKT (Kim et al., 2004; Liu et al., 2005). Our ﬁndings
also support the idea that there are additional signaling
networks that impact cell migration that are likely under
the inﬂuence of hTid-1. Notably, depletion of endogen-
ous hTid-1 proteins leads to a profound inhibition
of cell motility in HGF-treated cells, which correlates
with STAT3 inactivation. Furthermore, we also note
that hTid-1S overexpression provokes a marked
enhancement in the migratory potential of 786-0 cells
even under serum-starved conditions, indicating that
hTid-1 proteins can function through HGF-independent
pathways to inﬂuence cell migration, however, the
precise mechanisms remain to be elucidated.
In summary, our results point to hTid-1S as an
essential allosteric activator of the c-Met receptor in
RCCs. Evidence is accumulating that hTid-1 proteins
have disctinct chaperoning functions that impact a
large number of signaling effectors implicated in cell-
fate determination, cellular differentiation, prolifera-
tion, survival and invasion/metastasis. The mechanism
of action by which hTid-1 regulates the activity of these
client proteins will be key areas for future research.
Materials and methods
Cell lines and reagents
The human RCC cell line 786-0 has a germ-line VHL frameshift
mutation and does not express VHL. Parental 786-0 and 786-0
recombinants, in which VHL has been stably reintroduced
(786-OþVHL) were generously provided by Dr M Ohh
(University of Toronto). The NSCLC cell line A549 was kindly
provided by Dr M Tsao (University of Toronto). HEK293T and
MDA-MB-231 cells were purchased from ATCC (Manassas,
VA, USA). Antibodies to phospho-Met Y1234/5, phospho-Akt
Ser 473, Akt, phospho-STAT3, STAT3, phosphotyrosine
residues (4G10) and HRP-linked secondary antibodies were
purchased from Cell Signaling Technologies (Beverly, MA,
USA). Met (C28; C12) antibodies were from Santa Cruz
Biotechnology (Santa Cruz, CA, USA); Phospho-Erk1/2 and
Erk1/2 antibodies from Zymed Laboratories (San Francisco,
CA, USA); VHL antibodies from BD Biosciences (San Jose,
CA, USA). b-actin antibody and human recombinant HGF
were purchased from Sigma (Oakville, ON, Canada). The rabbit
polyclonal antibodies to hTid-1 were generated as described
(Trentin et al., 2001).
Adenoviral infections
Adenoviruses generated by cloning the complementary DNAs
of full-length hTid-1S and hTid-1L downstream of the CMV
promoter in pAdTrack-CMV have been previously described
(Trentin et al., 2001).
Lentiviral production and infections
The hTid-1 interfering RNA (RNAi) construct in the lentivirus
vector pLL3.7 along with the parental pLL3.7 vector was
kindly provided by Dr Isaiah J Fidler (The University
of Texas). The pLL3.7/hTid-1 RNAi plasmid was contra-
nsfected into the 293T packaging cell line with a 3rd generation
packaging system consisting of the vectors pMDLg/pRRE
(gag/pol elements), pRSV-REV and pMD.G (envelope
elements). The viral supernatant was harvested 48-h post
transfection and was used to transduce the 786-0 RCC cell line
in the presence of 8mg/ml polybrene.
GST fusion-protein preparation and pull-down experiments
GST-fusion constructs and pull-down assays have been
previously described (Trentin et al., 2001). Proteins bound to
GST-fusion proteins were subjected to western blot analysis
with the indicated antibodies.
Immunoprecipitation
For immunoprecipitation experiments cells were lysed in
modiﬁed RIPA, and the supernatant was pre-cleared with
100ml of a 10% protein-A agarose slurry. Protein determina-
tion was done via a Bradford assay on the pre-cleared lysate.
A measure of 800mg of cell lysate was immunoprecipitated
with 2mg of the indicated antibody and 100ml of a 10%
protein-A agarose slurry overnight at 41C. The protein-A
agarose beads were washed 3  with PLC buffer before
loading onto an sodium dodecyl sulfate–PAGE gel.
Immunoﬂuorescence
786-0 RCC were plated on BD 8-well chamber slides at 20000
cells per well and starved in serum-free DMEM for 48h. For
HGF stimulation, cells were incubated with 40ng/ml of HGF
(Peprotech, Rocky Hill, NJ, USA) in serum-free DMEM for
10min. Cells were ﬁxed with 2% Paraformaldehyde (PFA;
EMD) in phosphate-buffered saline (PBS) for 20min and
excess PFA was neutralized with 0.1 M Glycine/PBS for 5min.
Cells were brieﬂy washed with Glycine/PBS and permeabilized
with 0.5% Triton X-100/PBS for 10min at room temperature,
blocked with 5% BSA solution in PBS for 30min and
subsequently incubated overnight at 41C with primary
antibodies in blocking solution, at dilutions of 1:50 for both
Tid-1 and Met antibodies. Cells were washed extensively with
IF Wash Buffer (130mM NaCl, 7mM Na2HPO4, 3.5mM
NaH2PO4, 7.7mM NaN3, 0.1% BSA, 0.2% Triton X-100,
0.05% Tween-20) and incubated with secondary antibodies
(AlexaFluor488 (Anti-Rabbit; Invitrogen, Burlington, ON,
Canada) and Cy3 (Anti-Mouse; Jackson ImmunoResearch,
West Grove, PA, USA) at 1:200) in blocking solution (5%
BSA/PBS) for 1h at room temperature. Cells were washed
with IF wash Buffer and mounted with DAPI-containing
VECTASHIELD Mounting Medium. Images were captured
using a Zeiss LSM 410 Laser Scanning Confocal Microscope
(Zeiss, Toronto, ON, Canada) and analyzed with the appro-
priate software.
Transwell migration assay
786-0 RCC cells were resuspended in 500mL of serum-free
DMEM supplemented with 0.5% BSA and plated in the upper
chamber of an uncoated transwell chamber with an 8-mm pore
size (BD Biosciences). The lower chamber contained 500ml
of serum-free DMEM supplemented with 0.5% BSA and
40ng/ml HGF as a chemoattractant. After 24h of incubation,
the cells that migrated through the ﬁlter were stained
(Diff-Quik). Filters were mounted on slides with immersion
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Mississauga, ON, Canada). The number of cells that migrated
was counted in ﬁve individual ﬁelds/ﬁlter. Data shown
represents pooled data from three independent experiments.
Wound closure assay
786-0 cells were grown to conﬂuency and serum-starved
overnight in serum-free DMEM. A 200-ml pipette tip was
used to make a uniform wound in the cell layer. Cells were
washed thoroughly with serum-free DMEM and fresh serum-
free DMEM was added at 0h with or without the addition of
5ng/ml HGF where indicated. A Nikon TE2000 Eclipse was
used to photograph speciﬁc ﬁelds of the wound at the indicated
time points. These photographs were used to measure the
width of the wound using Simple PCI software (Mississauga,
ON, Canada) and percentage wound closure was calculated
using the following equation: % wound closure¼(1 wound
width at time  /wound width at 0h) 100. Data shown
represents pooled data from three independent experiments.
An unpaired t-test was used to calculate signiﬁcance of either
hTid-1S or hTid-1L overexpressing cells compared with the
control at each time point. A P value of o0.05 was considered
signiﬁcant.
Cell proliferation assay
Cells were infected with Ad-GFP, Ad-hTid-1S or Ad-hTid-1L.
The following day, 2500 cells were seeded/well of 24-well
plates. Cells were serum-starved overnight, and left untreated
or stimulated with the indicated concentration of HGF.
The media was changed every 48h to fresh starvation media
with HGF. Cells were counted manually at the indicated time
points after infection using trypan blue exclusion. Growth
assays were performed at least three independent times.
Densitometric analysis
Densitometric analysis of western blot results was performed
using Scion Image software (Scion Corp., Frederick, MD,
USA). The pixel densities for both the phosphorylated protein
and total protein as indicated were determined and were
expressed as a ratio of phosphorylated protein:total protein.
Statistical analysis
A student’s t-test was used to compare each experimental
condition with the control condition. A P-value of o0.05 was
considered signiﬁcant.
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